Brendan Farrell, Chief Executive Officer of Trinity Biotech plc., rings the NASDAQ Closing Bell
June 27, 2008 - Trinity Biotech plc [TRIB]
About this Marketsite Event:
Brendan Farrell, Chief Executive Officer of Trinity Biotech plc, presides over the Closing Bell in recognition of National HIV Testing Day. Joining him at the podium are Dr. Monica Sweeney, Assistant Commissioner, Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Dennis deLeon, President, Latino Commission on AIDS.
About Trinity Biotech plc [TRIB] :
Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own salesforce and a network of international distributors and strategic partners.
Press Inquiries Only:
Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at
jolene.libretto@nasdaq.com. Kindly credit © 2008, The Nasdaq Stock Market, Inc. Reprinted with permission.
Other Photography Inquiries:
For all other photography inquiries, please contact NASDAQ’s photographer, Rob Tannenbaum at
rob.tannenbaum@nasdaq.com.
© 2008, The NASDAQ OMX Group, Inc. Reprinted with permission.
